Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test
Vivos will receive 50% of the contribution margin from sales of the diagnostic test across all channels.
Educating the medical device manufacturing industry since 2002.
Vivos will receive 50% of the contribution margin from sales of the diagnostic test across all channels.
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns